A. Schneider

发表

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients

Paul J. Hoover, N. Hacohen, A. Villani, 2020, bioRxiv.

From Benzene to Graphene: Exploring the Electronic Structure of Single-Layer and Bilayer Graphene Using Polycyclic Aromatic Hydrocarbons

K. Sohlberg, A. Schneider, Janna Domenico, 2019, Journal of Chemical Education.

SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.

N. Hacohen, A. Villani, B. M. Lilley, 2021, The Journal of clinical investigation.

Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions

Paul J. Hoover, N. Hacohen, A. Villani, 2021, Cell Reports Medicine.

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

N. Hacohen, R. Sullivan, K. Flaherty, 2022, bioRxiv.

SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes

N. Hacohen, A. Villani, B. M. Lilley, 2021, medRxiv.

IRF3 inhibits IFN‐γ‐mediated restriction of intracellular pathogens in macrophages independently of IFNAR

R. Raychowdhury, N. Hacohen, Schraga Schwartz, 2021, Journal of leukocyte biology.

Targeting TBK1 to overcome resistance to cancer immunotherapy

N. Hacohen, A. Giobbie-Hurder, P. Sorger, 2022, Nature.

Optogenetic Peripheral Nerve Immunogenicity

Claudia E Varela, Benjamin E Maimon, Maurizio Diaz, 2018, Scientific Reports.

150 Circulatory plasma proteomic biomarkers predict response to immunotherapy in melanoma patients and reveal biological insights into the tumor microenvironment

N. Hacohen, K. Flaherty, Dennie T. Frederick, 2022, Regular and Young Investigator Award Abstracts.